Jonathan Lieber has almost 30 years of experience in financial and executive management at emerging and growth-stage life sciences companies, as well as in investment banking. As a chief financial officer, Mr. Lieber has helped raise more than $300 million of equity and debt in public and private offerings, including a $110 million initial public offering at Altus Pharmaceuticals, and led myriad strategic and business development transactions, including the successful sale of Xcellerex to GE Healthcare. Mr. Lieber currently serves as Managing Director, New England for Danforth Advisors, a consulting firm providing operational accounting and finance support, together with CFO services, for private and public life science companies. Previously, he served as CFO of Histogenics Corporation, a publicly traded cell therapy company developing products for the orthopedics market. Mr. Lieber also served as CFO of Metamark Genetics, Inc., and CFO and Treasurer of Repligen Corporation. Previously, Mr. Lieber worked as an investment banker for almost 10 years, during which time he originated and executed on numerous corporate financings and M&A transactions at SG Cowen and Salomon Brothers. Mr. Lieber earned a B.S. in Business Administration and Finance from Boston University and was awarded a M.B.A. in Finance from New York University Stern School of Business.